Graham Capital Management, L.P. Catalyst Pharmaceuticals, Inc. Transaction History
Graham Capital Management, L.P.
- $5.08 Billion
- Q4 2024
A detailed history of Graham Capital Management, L.P. transactions in Catalyst Pharmaceuticals, Inc. stock. As of the latest transaction made, Graham Capital Management, L.P. holds 24,905 shares of CPRX stock, worth $614,904. This represents 0.01% of its overall portfolio holdings.
Number of Shares
24,905
Previous 34,195
27.17%
Holding current value
$614,904
Previous $679,000
23.56%
% of portfolio
0.01%
Previous 0.02%
Shares
6 transactions
Others Institutions Holding CPRX
# of Institutions
348Shares Held
98.4MCall Options Held
13.4KPut Options Held
11.7K-
Black Rock Inc. New York, NY18.7MShares$462 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.43MShares$208 Million0.0% of portfolio
-
State Street Corp Boston, MA5.8MShares$143 Million0.0% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY3.13MShares$77.4 Million1.62% of portfolio
-
Dimensional Fund Advisors LP Austin, TX3.01MShares$74.4 Million0.02% of portfolio
About CATALYST PHARMACEUTICALS, INC.
- Ticker CPRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 102,820,000
- Market Cap $2.54B
- Description
- Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases in the United States. It offers Firdapse, an amifampridine phosphate tablets for the treatment of patients with lambert-eaton myasthe...